When Johnson and Johnson (J&J) filed with the Securities Exchange recently, it didn’t hide the fact that it was facing more than 13,000 lawsuits involving the antipsychotic drug Risperdal. This isn’t surprising considering that the drug, which is … [Read more...]
Manufacturer Loses Risperdal Gynecomastia Case
By Desiree Housek, Staff Writer Families have been filing legal claims against Johnson & Johnson and its Janssen Pharmaceuticals unit, which is responsible for Risperdal, an antipsychotic drug. The drug has been associated with causing male … [Read more...]